i-Base home
Search Menu
  • Home
  • HTB
  • Conference reports
  • 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 16-19 December 2001

HTB

41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 16-19 December 2001

9 January 2002. Related: Conference reports, Conference index, ICAAC 41st Chicago 2001.

Report from the conference.

  • Low dose pegylated interferon is ineffective in treating HIV/HCV co-infected patients
  • Phenotypic resistance to ddI is less frequent than resistance to ZDV, 3TC and abacavir
  • Impact of Kaletra on amprenavir plasma concentrations in HIV treatment-experienced patients
  • Immune reconstitution more difficult with low baseline CD4+ T cell counts
  • HIV-1 may revert to less pathogenic strain a few days after starting HAART
  • Change from CCR5 to CXCR4 phenotype may affect immunologic responses
  • ddI EC (Videx) study confirms and clarifies dosing on an empty stomach
  • Swatch study: should we be cycling drugs?
  • New HIV drugs, resistance, pharmacogenomics
  • Antiretroviral therapy
  • Immunopathogenesis of HIV infection

Links to other websites are current at date of posting but not maintained.

  • HTB RSS
  • Low dose pegylated interferon is ineffective in treating HIV/HCV co-infected patients
  • The Chapman Clinic: musculoskeletal treatment for patients with HIV

Early access

  • Outcomes of 54 cases of monkeypox (MPX) in London: fewer early symptoms but higher rates of genital lesions – urgency of funding sexual health 2 July 2022
  • All early access reports

Current issues

  • July 2022
  • June 2022
  • May 2022
  • Back issues

Special report

  • Monkeypox crisis in the UK needs urgent funding: sex, vaccines and Pride 1 July 2022

More from HTB

  • Conference reports
  • Conference shortcuts
  • Articles by subject
  • PDFs
  • Subscribe
  • HTB homepage

Home

  • i-Base homepage

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

This site complies with the HONcode standard for trustworthy health information.

Verify here.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
107 The Maltings, 169 Tower Bridge Road, London SE1 3LJ.
Tel + 44 (0) 208 616 2210. Email admin@i-base.org.uk
Registered charity no: 1081905. Company reg no: 3962064.

Search i-Base

Site navigation

Quick links
HIV positive
Advocate
Professional
Donate
Feedback
Advice and information
Q and A
Phoneline
Pocket info
Guides
HIV meds
Glossary
Research and conference reports
HTB
HTB South
Pipeline report
Publications and resources
Publications
Other resources
Translations
Slide sets
Order and subscribe
News and updates
News
Blogs
Advocates' network
UK-CAB
Training manual
i-Base
About us
Contact
Sitemap
Home
Find us on Facebook
i-Base on Facebook